Northwire Canada EditionSaturday, October 17, 2026
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%

Healthcare

Page 70
  1. Jan 23, 2026 · 18:57 · JNH

    Jack Nathan names co-founder Di Cesare as interim CEO

    Jack Nathan names co-founder Di Cesare as interim CEO

    01
  2. Jan 23, 2026 · 18:07 · VIVI

    Tempramed Technologies releases VIVI Med

    Tempramed Technologies releases VIVI Med

    02
  3. Jan 23, 2026 · 17:39 · JNH

    Jack Nathan Medical Corp. Announces CEO Transition and Strategic Investor Alignment

    Jack Nathan Medical Corp. Announces CEO Transition and Strategic Investor Alignment

    03
  4. Jan 23, 2026 · 16:54 · CRDL

    Cardiol closes $14.85-million bought deal financing

    Cardiol closes $14.85-million bought deal financing

    04
  5. Jan 23, 2026 · 16:11 · BNXT

    Bionxt Solutions to issue six million shares for debt

    Bionxt Solutions to issue six million shares for debt

    05
  6. Jan 23, 2026 · 16:09 · BHC

    Bausch Health's RED-C trials fail to meet end point

    Bausch Health's RED-C trials fail to meet end point

    06
  7. Jan 23, 2026 · 16:06 · VIVI

    TempraMed Launches New Product "VIVI Med(TM)," Unlocking New Growth Opportunities in High-Value Biologics and Injectable Medications

    TempraMed Launches New Product "VIVI Med(TM)," Unlocking New Growth Opportunities in High-Value Biologics and Injectable Medications

    07
  8. Jan 23, 2026 · 14:28 · AJA

    Aja Health and Wellness Inc. Announces Agreement Between Assured Diagnosis Inc. and Greatway Financial Inc. and Implementation of New Electronic Medical Records Software for GOeVisit

    Aja Health and Wellness Inc. Announces Agreement Between Assured Diagnosis Inc. and Greatway Financial Inc. and Implementation of New Electronic Medical Records Software for GOeVisit

    08
  9. Jan 23, 2026 · 09:17 · CRDL

    Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million

    Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million

    09
  10. Jan 23, 2026 · 09:01 · TTI

    Thiogenesis Presents Phase 2 (EU) MELAS Data at Mitocon 2026

    Thiogenesis Presents Phase 2 (EU) MELAS Data at Mitocon 2026

    10
  11. Jan 23, 2026 · 07:45 · BHC

    Bausch Health Provides Update on RED-C Phase 3 Clinical Trials

    Bausch Health Provides Update on RED-C Phase 3 Clinical Trials

    11
  12. Jan 22, 2026 · 18:00 · SKNY

    LIR Life Sciences Completes Design of Ex Vivo Animal Study to Evaluate Novel Transdermal Agents for Transport of Larger Therapeutic Molecules

    LIR Life Sciences Completes Design of Ex Vivo Animal Study to Evaluate Novel Transdermal Agents for Transport of Larger Therapeutic Molecules

    12
  13. Jan 22, 2026 · 17:45 · AIDR

    ROCKET DOCTOR AI INC. ANNOUNCES CLOSING OF LISTED ISSUER FINANCING EXEMPTION (LIFE) PRIVATE PLACEMENT OF UNITS

    ROCKET DOCTOR AI INC. ANNOUNCES CLOSING OF LISTED ISSUER FINANCING EXEMPTION (LIFE) PRIVATE PLACEMENT OF UNITS

    13
  14. Jan 22, 2026 · 17:01 · FNDX

    FendX and Aquaox Enter into Collaboration Agreement to Pursue Innovation in Eco-Friendly Antimicrobial Agents

    FendX and Aquaox Enter into Collaboration Agreement to Pursue Innovation in Eco-Friendly Antimicrobial Agents

    14
← Newer Older →